![Cancers | Free Full-Text | Metabolism-Associated Epigenetic and Immunoepigenetic Reprogramming in Liver Cancer Cancers | Free Full-Text | Metabolism-Associated Epigenetic and Immunoepigenetic Reprogramming in Liver Cancer](https://pub.mdpi-res.com/cancers/cancers-13-05250/article_deploy/html/images/cancers-13-05250-g001.png?1634805459)
Cancers | Free Full-Text | Metabolism-Associated Epigenetic and Immunoepigenetic Reprogramming in Liver Cancer
![PDF) Ganten TM, Koschny R, Sykora J, Schulze-Bergkamen H, Buchler P, Haas TL, Schader MB, Untergasser A, Stremmel W, Walczak HPreclinical differentiation between apparently safe and potentially hepatotoxic applications of TRAIL either PDF) Ganten TM, Koschny R, Sykora J, Schulze-Bergkamen H, Buchler P, Haas TL, Schader MB, Untergasser A, Stremmel W, Walczak HPreclinical differentiation between apparently safe and potentially hepatotoxic applications of TRAIL either](https://i1.rgstatic.net/publication/7141955_Ganten_TM_Koschny_R_Sykora_J_Schulze-Bergkamen_H_Buchler_P_Haas_TL_Schader_MB_Untergasser_A_Stremmel_W_Walczak_HPreclinical_differentiation_between_apparently_safe_and_potentially_hepatotoxic_applicat/links/56ec0df408aee4707a384e60/largepreview.png)
PDF) Ganten TM, Koschny R, Sykora J, Schulze-Bergkamen H, Buchler P, Haas TL, Schader MB, Untergasser A, Stremmel W, Walczak HPreclinical differentiation between apparently safe and potentially hepatotoxic applications of TRAIL either
Design, Synthesis, and Preclinical Evaluation of Fused Pyrimidine-Based Hydroxamates for the Treatment of Hepatocellular Carcinoma | Journal of Medicinal Chemistry
![Advances in targeted therapies for hepatocellular carcinoma in the genomic era | Nature Reviews Clinical Oncology Advances in targeted therapies for hepatocellular carcinoma in the genomic era | Nature Reviews Clinical Oncology](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fnrclinonc.2015.103/MediaObjects/41571_2015_Article_BFnrclinonc2015103_Fig1_HTML.jpg)
Advances in targeted therapies for hepatocellular carcinoma in the genomic era | Nature Reviews Clinical Oncology
![Cancers | Free Full-Text | Double-Edged Lipid Nanoparticles Combining Liposome-Bound TRAIL and Encapsulated Doxorubicin Showing an Extraordinary Synergistic Pro-Apoptotic Potential Cancers | Free Full-Text | Double-Edged Lipid Nanoparticles Combining Liposome-Bound TRAIL and Encapsulated Doxorubicin Showing an Extraordinary Synergistic Pro-Apoptotic Potential](https://pub.mdpi-res.com/cancers/cancers-11-01948/article_deploy/html/images/cancers-11-01948-g003.png?1577713024)
Cancers | Free Full-Text | Double-Edged Lipid Nanoparticles Combining Liposome-Bound TRAIL and Encapsulated Doxorubicin Showing an Extraordinary Synergistic Pro-Apoptotic Potential
![Generation of TRAIL-resistant cell line models reveals distinct adaptive mechanisms for acquired resistance and re-sensitization | Oncogene Generation of TRAIL-resistant cell line models reveals distinct adaptive mechanisms for acquired resistance and re-sensitization | Oncogene](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41388-021-01697-6/MediaObjects/41388_2021_1697_Fig1_HTML.png)
Generation of TRAIL-resistant cell line models reveals distinct adaptive mechanisms for acquired resistance and re-sensitization | Oncogene
![The POU4F2/Brn-3b transcription factor is required for the hypertrophic response to angiotensin II in the heart | Cell Death & Disease The POU4F2/Brn-3b transcription factor is required for the hypertrophic response to angiotensin II in the heart | Cell Death & Disease](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41419-019-1848-y/MediaObjects/41419_2019_1848_Fig1_HTML.png)
The POU4F2/Brn-3b transcription factor is required for the hypertrophic response to angiotensin II in the heart | Cell Death & Disease
![Liver Retransplantation in Patients With HIV-1 Infection: An International Multicenter Cohort Study - American Journal of Transplantation Liver Retransplantation in Patients With HIV-1 Infection: An International Multicenter Cohort Study - American Journal of Transplantation](https://www.amjtransplant.org/cms/asset/f29b61d4-3e99-4f06-9174-048bc774d57c/gr1.jpg)
Liver Retransplantation in Patients With HIV-1 Infection: An International Multicenter Cohort Study - American Journal of Transplantation
![Specific downregulation of cFLIP by siRNA is sufficient to sensitise... | Download Scientific Diagram Specific downregulation of cFLIP by siRNA is sufficient to sensitise... | Download Scientific Diagram](https://www.researchgate.net/profile/Tom-Ganten/publication/8598891/figure/fig8/AS:267957850865676@1440897538498/Specific-downregulation-of-cFLIP-by-siRNA-is-sufficient-to-sensitise-Hep3b-cells-for_Q640.jpg)
Specific downregulation of cFLIP by siRNA is sufficient to sensitise... | Download Scientific Diagram
![Novel Integrative Approaches to the Identification of Candidate Genes in Hypertension | Hypertension Novel Integrative Approaches to the Identification of Candidate Genes in Hypertension | Hypertension](https://www.ahajournals.org/cms/asset/209be0c3-8481-4ddc-a36a-047fb131b374/1ff1.jpeg)
Novel Integrative Approaches to the Identification of Candidate Genes in Hypertension | Hypertension
![IJMS | Free Full-Text | The Melanocortin System: A Promising Target for the Development of New Antidepressant Drugs IJMS | Free Full-Text | The Melanocortin System: A Promising Target for the Development of New Antidepressant Drugs](https://www.mdpi.com/ijms/ijms-24-06664/article_deploy/html/images/ijms-24-06664-g001.png)
IJMS | Free Full-Text | The Melanocortin System: A Promising Target for the Development of New Antidepressant Drugs
![p53 is not required for 5-FU ability to sensitize HCC cell lines to... | Download Scientific Diagram p53 is not required for 5-FU ability to sensitize HCC cell lines to... | Download Scientific Diagram](https://www.researchgate.net/publication/46578469/figure/fig3/AS:964592247250948@1606988121541/p53-is-not-required-for-5-FU-ability-to-sensitize-HCC-cell-lines-to-TRAIL-induced.png)